AZD 3427 (Relaxin-FC ThP) (NCT04890548)

A Phase 1A/B randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and
Pharmacokinetics of Single Ascending Doses of AZD3427 in Healthy Volunteers and Multiple Ascending Doses of AZD3427
in Patients with Heart Failure (HFrEF and HFpEF)

PI: Emerson Perin, MD, PhD
Sponsor: AstraZeneca

ACTIVE ENROLLING  SIGN UP